[HTML][HTML] Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles

J Morry, W Ngamcherdtrakul, W Yantasee - Redox biology, 2017 - Elsevier
Oxidative stress, mainly contributed by reactive oxygen species (ROS), has been implicated
in pathogenesis of several diseases. We review two primary examples; fibrosis and cancer …

Idiopathic pulmonary fibrosis

TJ Gross, GW Hunninghake - New England Journal of Medicine, 2001 - Mass Medical Soc
Idiopathic pulmonary fibrosis is characterized by radiographically evident interstitial
infiltrates predominantly affecting the lung bases and by progressive dyspnea and …

A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis

I Noth, KJ Anstrom, SB Calvert… - American journal of …, 2012 - atsjournals.org
Rationale: Animal and human studies support the importance of the coagulation cascade in
pulmonary fibrosis. Objectives: In a cohort of subjects with progressive idiopathic pulmonary …

Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis

TJ Richards, N Kaminski, F Baribaud… - American journal of …, 2012 - atsjournals.org
Rationale: Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease of unknown etiology
with a variable and unpredictable course. Objectives: The aim of this study was to identify …

Modeling pulmonary fibrosis with bleomycin

MA Mouratis, V Aidinis - Current opinion in pulmonary medicine, 2011 - journals.lww.com
Despite its disadvantages, the bleomycin animal model remains the best available
experimental tool for studying disease pathogenesis and testing of novel pharmaceutical …

Targeting the redox balance in inflammatory skin conditions

FA Wagener, CE Carels, DMS Lundvig - International journal of molecular …, 2013 - mdpi.com
Reactive oxygen species (ROS) can be both beneficial and deleterious. Under normal
physiological conditions, ROS production is tightly regulated, and ROS participate in both …

Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis

CR Kliment, TD Oury - Free Radical Biology and Medicine, 2010 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by
progressive fibrosis of the alveolar interstitium. The pathogenesis is thought to involve …

Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review

AG Fois, P Paliogiannis, S Sotgia, AA Mangoni… - Respiratory …, 2018 - Springer
Introduction Idiopathic pulmonary fibrosis (IPF), a fatal lung disease of unknown origin, is
characterized by chronic and progressive fibrosing interstitial pneumonia which …

Lipid peroxidation and GPX4 inhibition are common causes for myofibroblast differentiation and ferroptosis

Y Gong, N Wang, N Liu, H Dong - DNA and Cell Biology, 2019 - liebertpub.com
Ferroptosis is a new form of regulated cell death. Fibroblast-to-myofibroblast differentiation is
known to be involved in the pathogenesis of idiopathic pulmonary fibrosis. Utilizing HFL1 …

Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 …

J Behr, E Bendstrup, B Crestani, A Günther… - The Lancet …, 2016 - thelancet.com
Background Oral acetylcysteine (also known as N-acetylcysteine) is used with pirfenidone to
treat idiopathic pulmonary fibrosis (IPF) in Europe. However, no randomised studies have …